vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and PATRICK INDUSTRIES INC (PATK). Click either name above to swap in a different company.

PATRICK INDUSTRIES INC is the larger business by last-quarter revenue ($924.2M vs $493.8M, roughly 1.9× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 3.1%, a 3.7% gap on every dollar of revenue. On growth, PATRICK INDUSTRIES INC posted the faster year-over-year revenue change (9.2% vs -1.7%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -0.5%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

Anduril Industries, Inc. is an American defense technology company specializing in the development of advanced autonomous systems.

MD vs PATK — Head-to-Head

Bigger by revenue
PATK
PATK
1.9× larger
PATK
$924.2M
$493.8M
MD
Growing faster (revenue YoY)
PATK
PATK
+10.9% gap
PATK
9.2%
-1.7%
MD
Higher net margin
MD
MD
3.7% more per $
MD
6.8%
3.1%
PATK
Faster 2-yr revenue CAGR
MD
MD
Annualised
MD
-0.1%
-0.5%
PATK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MD
MD
PATK
PATK
Revenue
$493.8M
$924.2M
Net Profit
$33.7M
$29.1M
Gross Margin
23.0%
Operating Margin
9.9%
6.2%
Net Margin
6.8%
3.1%
Revenue YoY
-1.7%
9.2%
Net Profit YoY
10.5%
99.7%
EPS (diluted)
$0.40
$0.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
PATK
PATK
Q4 25
$493.8M
$924.2M
Q3 25
$492.9M
$975.6M
Q2 25
$468.8M
$1.0B
Q1 25
$458.4M
$1.0B
Q4 24
$502.4M
$846.1M
Q3 24
$511.2M
$919.4M
Q2 24
$504.3M
$1.0B
Q1 24
$495.1M
$933.5M
Net Profit
MD
MD
PATK
PATK
Q4 25
$33.7M
$29.1M
Q3 25
$71.7M
$35.3M
Q2 25
$39.3M
$32.4M
Q1 25
$20.7M
$38.2M
Q4 24
$30.5M
$14.6M
Q3 24
$19.4M
$40.9M
Q2 24
$-153.0M
$47.9M
Q1 24
$4.0M
$35.1M
Gross Margin
MD
MD
PATK
PATK
Q4 25
23.0%
Q3 25
22.6%
Q2 25
23.9%
Q1 25
22.8%
Q4 24
22.1%
Q3 24
23.1%
Q2 24
22.8%
Q1 24
21.9%
Operating Margin
MD
MD
PATK
PATK
Q4 25
9.9%
6.2%
Q3 25
13.8%
6.8%
Q2 25
12.8%
8.3%
Q1 25
7.0%
6.5%
Q4 24
7.8%
4.7%
Q3 24
6.6%
8.1%
Q2 24
-31.3%
8.3%
Q1 24
3.2%
6.4%
Net Margin
MD
MD
PATK
PATK
Q4 25
6.8%
3.1%
Q3 25
14.5%
3.6%
Q2 25
8.4%
3.1%
Q1 25
4.5%
3.8%
Q4 24
6.1%
1.7%
Q3 24
3.8%
4.4%
Q2 24
-30.3%
4.7%
Q1 24
0.8%
3.8%
EPS (diluted)
MD
MD
PATK
PATK
Q4 25
$0.40
$0.82
Q3 25
$0.84
$1.01
Q2 25
$0.46
$0.96
Q1 25
$0.24
$1.11
Q4 24
$0.37
$-1.44
Q3 24
$0.23
$1.80
Q2 24
$-1.84
$2.16
Q1 24
$0.05
$1.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
PATK
PATK
Cash + ST InvestmentsLiquidity on hand
$375.2M
$26.4M
Total DebtLower is stronger
$570.5M
$1.3B
Stockholders' EquityBook value
$865.9M
$1.2B
Total Assets
$2.2B
$3.1B
Debt / EquityLower = less leverage
0.66×
1.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
PATK
PATK
Q4 25
$375.2M
$26.4M
Q3 25
$340.1M
$20.7M
Q2 25
$224.7M
$22.0M
Q1 25
$99.0M
$86.6M
Q4 24
$229.9M
$33.6M
Q3 24
$103.8M
$52.6M
Q2 24
$19.4M
$44.0M
Q1 24
$8.0M
$17.6M
Total Debt
MD
MD
PATK
PATK
Q4 25
$570.5M
$1.3B
Q3 25
$577.2M
Q2 25
$583.9M
Q1 25
$590.5M
Q4 24
$597.1M
$1.3B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MD
MD
PATK
PATK
Q4 25
$865.9M
$1.2B
Q3 25
$890.7M
$1.2B
Q2 25
$833.8M
$1.1B
Q1 25
$789.2M
$1.1B
Q4 24
$764.9M
$1.1B
Q3 24
$732.5M
$1.1B
Q2 24
$706.5M
$1.1B
Q1 24
$856.2M
$1.1B
Total Assets
MD
MD
PATK
PATK
Q4 25
$2.2B
$3.1B
Q3 25
$2.2B
$3.1B
Q2 25
$2.1B
$3.1B
Q1 25
$2.0B
$3.2B
Q4 24
$2.2B
$3.0B
Q3 24
$2.1B
$3.1B
Q2 24
$2.0B
$3.0B
Q1 24
$2.2B
$3.0B
Debt / Equity
MD
MD
PATK
PATK
Q4 25
0.66×
1.10×
Q3 25
0.65×
Q2 25
0.70×
Q1 25
0.75×
Q4 24
0.78×
1.18×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
PATK
PATK
Operating Cash FlowLast quarter
$114.1M
$130.8M
Free Cash FlowOCF − Capex
$112.7M
FCF MarginFCF / Revenue
12.2%
Capex IntensityCapex / Revenue
2.0%
Cash ConversionOCF / Net Profit
3.39×
4.50×
TTM Free Cash FlowTrailing 4 quarters
$246.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
PATK
PATK
Q4 25
$114.1M
$130.8M
Q3 25
$137.3M
$9.1M
Q2 25
$137.2M
$149.4M
Q1 25
$-117.5M
$40.1M
Q4 24
$133.0M
$102.7M
Q3 24
$91.8M
$51.5M
Q2 24
$107.0M
$137.5M
Q1 24
$-125.2M
$35.2M
Free Cash Flow
MD
MD
PATK
PATK
Q4 25
$112.7M
Q3 25
$-17.2M
Q2 25
$131.1M
Q1 25
$19.9M
Q4 24
$77.2M
Q3 24
$33.7M
Q2 24
$120.6M
Q1 24
$19.7M
FCF Margin
MD
MD
PATK
PATK
Q4 25
12.2%
Q3 25
-1.8%
Q2 25
12.5%
Q1 25
2.0%
Q4 24
9.1%
Q3 24
3.7%
Q2 24
11.9%
Q1 24
2.1%
Capex Intensity
MD
MD
PATK
PATK
Q4 25
2.0%
Q3 25
2.7%
Q2 25
1.7%
Q1 25
2.0%
Q4 24
3.0%
Q3 24
1.9%
Q2 24
1.7%
Q1 24
1.7%
Cash Conversion
MD
MD
PATK
PATK
Q4 25
3.39×
4.50×
Q3 25
1.91×
0.26×
Q2 25
3.49×
4.61×
Q1 25
-5.66×
1.05×
Q4 24
4.36×
7.05×
Q3 24
4.72×
1.26×
Q2 24
2.87×
Q1 24
-31.03×
1.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

PATK
PATK

Recreational Vehicle$276.3M30%
Distribution$222.4M24%
Marine$141.9M15%
Industrial$110.8M12%
Powersports$104.8M11%
Manufactured Housing$67.9M7%

Related Comparisons